Rep. Kevin Hern (R-OK) Sells MRSH Stock
Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan valued between $50,001 and $100,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Kevin Hern (R-OK) sold between $50,001 and $100,000 of Marsh & McLennan Companies, Inc. ($MRSH) stock on September 23, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 13, 2026.
Since the trade, $MRSH is up 0.2% after 1 week and up 11.2% to date (from the $169.39 close on Sep 23, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Kevin Hern (R-OK)
- Status:
- Member — House
- State/District:
- OK-1
- Party:
- Republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 13, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Marsh & McLennan Companies, Inc. ($MRSH) | Sell | Sep 23, 2026 | $50,001 - $100,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
Key Points
- On September 23, 2026, Rep. Kevin Hern sold shares of Marsh & McLennan Companies (MRSH) valued between $50,001 and $100,000.
- The stock recently traded around $188.36, which is above its 50-day and 200-day moving averages by 3.9% and 6.6%, respectively.
- Analysts have mixed views on the stock, with a consensus target price of $202.52, indicating it trades below this target.
Get $MRSH trade alerts by text
We text you when insiders, Congress or big funds trade $MRSH. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Marsh & McLennan Companies, Inc. alert may contain errors. Disclosures
Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan Companies, Inc. (MRSH) on September 23, 2026. The sale was valued between $50,001 and $100,000, according to a periodic transaction report filed under the STOCK Act on October 13, 2026.
Kevin Hern vs. the S&P 500
Hypothetical returns from Kevin Hern's disclosed trades, not real profit or advice. How we model this.
Inside Kevin Hern's Trade
Kevin Hern's recent sale of Marsh & McLennan shares reflects a strategic adjustment in his portfolio. This transaction adds to his previous sales of stocks from other companies, including TJX Companies and Starbucks, both made on September 2, 2026.
Other Institutional Activity in Marsh & McLennan
Several other institutional investors have adjusted their positions in Marsh & McLennan. Blackrock Inc. trimmed its stake by 2,561,681 shares, leaving it with 39,502,046 shares worth about $7.44 billion. Vanguard Capital Management LLC added 6,293 shares, bringing its total to 31,472,575 shares valued at approximately $5.93 billion. State Street Corporation increased its holdings by 331,059 shares, ending with 22,401,676 shares valued at around $4.22 billion. Meanwhile, Capital World Investors added 152,742 shares for a total of 18,122,340 shares worth about $3.41 billion. Wellington Management Group reduced its stake by 396,066 shares, now holding 16,975,238 shares valued at about $3.20 billion.
Marsh & McLennan Companies, Inc. Stock Up 1.0%
Marsh & McLennan shares are currently trading at $188.36, which is above both the 50-day moving average of $181.38 and the 200-day moving average of $176.70. However, the stock is about 5.1% below its 52-week high of $198.49. The recent price is also 7% below the mean target price of $202.52 set by analysts.
Recent Earnings
In its most recent financial performance, Marsh & McLennan reported trailing twelve-month revenue of approximately $28.46 billion, with an earnings per share (EPS) of $8.18. The company has shown a revenue growth of 8.1% year-over-year and maintains a net margin of 14.2%. The next earnings report is scheduled for January 28, 2027.
Dividend
Marsh & McLennan pays an annual dividend of $3.96 per share, which translates to a yield of 2.12%. The company's dividend payout ratio stands at 44.1%, indicating a balanced approach to returning value to shareholders while retaining earnings for growth.
Insider Buying and Selling at Marsh & McLennan Companies, Inc.
Several insiders have sold shares of Marsh & McLennan recently. Chief Executive Officer John Q Doyle sold 16,656 shares on September 2, 2026, at an average price of $188.51, totaling about $3.14 million. Other insiders, including Chief Technology Officer Paul Beswick and General Counsel Katherine J. Brennan, also sold shares in previous months, reflecting a broader trend of insider selling.
Analysts Set New Price Targets
On October 1, 2026, JP Morgan maintained its Overweight rating on Marsh & McLennan with a price target of $215.00. Morgan Stanley, however, adjusted its target down to $180.00 on October 6, 2026, while maintaining an Equal-Weight rating. UBS also maintained a Buy rating with a target of $222.00 on the same date. Overall, analysts have a consensus recommendation of Hold with a mean target price of $202.52.
About Marsh & McLennan
Marsh & McLennan Companies, Inc. is a professional services firm that offers advisory services and insurance solutions globally. The company operates through various segments, including Risk and Insurance Services and Consulting, helping clients manage risk and develop strategic solutions. This diverse portfolio positions Marsh & McLennan as a key player in the financial services sector, which is vital for many businesses.
Bottom Line
Investors will be watching Marsh & McLennan closely as the company approaches its next earnings report on January 28, 2027. With mixed analyst opinions and recent insider activity, there may be more developments to follow regarding the stock's performance and investor sentiment.
Source: Kevin Hern's STOCK Act disclosure on $MRSH (Sep 23, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts
